This application relates to compounds of Formula I:
or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
[EN] URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'URACILE COMME INHIBITEURS D'AXL ET C-MET KINASES
申请人:CEPHALON INC
公开号:WO2013074633A1
公开(公告)日:2013-05-23
The present invention provides compounds of Formula I, or pharmaceutically acceptable salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, R1a, R1b, R1c,Y, R3, X, E and G are as defined herein, methods of treatment and uses thereof.
This application relates to compounds of Formula I:
or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
本申请涉及式 I 的化合物:
或其药学上可接受的盐类,它们是 TAM 激酶的抑制剂,可用于治疗癌症等疾病。
Salts of TAM inhibitors
申请人:Incyte Corporation
公开号:US10633387B2
公开(公告)日:2020-04-28
The present application provides salt forms of N-(4-(4-Amino-7-(1-isobutyrylpiperidin-4-yl)pyrrolo[1,2-f][1,2,4]triazin-5-yl)phenyl)-1-isopropyl-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide and N-(4-(4-Amino-7-(1-isobutyrylpiperidin-4-yl)pyrrolo[1,2-f][1,2,4]triazin-5-yl)phenyl)-1-isopropyl-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamide, which are useful as inhibitors of TAM kinases, as well as processes and intermediates related thereto.
本申请提供了 N-(4-(4-氨基-7-(1-异丁酰基哌啶-4-基)吡咯并[1,2-f][1,2,4]三嗪-5-基)苯基)-1-异丙基-2、2-f][1,2,4]三嗪-5-基)苯基)-1-异丙基-2,4-二氧代-3-苯基-1,2,3,4-四氢嘧啶-5-甲酰胺,它们是有用的 TAM 激酶抑制剂,以及与之相关的过程和中间产物。